John K. Scott Jr. - 27 Nov 2023 Form 4 Insider Report for NAVIDEA BIOPHARMACEUTICALS, INC.

Reporting relationship: Director, 10%+ Owner
Issuer ticker: N/A
Reported as of: 27 Nov 2023
Net transaction value: +$4,028,900
SEC form: 4
Accepted by SEC: 05 Dec 2023, 18:26:20 UTC
Prior SEC filing: 30 Jun 2023
Source filing: View source filing
Reporting owner signature: Gioia Gentile on behalf of John K. Scott, Jr., by power of attorney

Key filing fact

John K. Scott Jr. filed Form 4 for NAVIDEA BIOPHARMACEUTICALS, INC. on 05 Dec 2023.

Key facts

This page summarizes John K. Scott Jr.'s Form 4 filing for NAVIDEA BIOPHARMACEUTICALS, INC..
3 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 05 Dec 2023, 18:26.

Change

Previous filing in this sequence was filed on 30 Jun 2023.
Current net transaction value: +$4,028,900.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NAVB transaction

Series G Redeemable Preferred Stock

Other

Transaction value
Shares: -2,270
Change %: -100%
Price
Shares after: 0
Date: 27 Nov 2023
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NAVB transaction Derivative

Series I Convertible Preferred Stock

Other

Transaction value: $2,400,000
Shares: -2,400
Change %: -100%
Price: $1000.00^*
Shares after: 0
Date: 27 Nov 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 15,000,000
Exercise price: $0.1600
Footnotes: F1, F2

NAVB transaction Derivative

Series J Convertible Preffered Stock

Other

Transaction value: $6,428,900
Shares: +64,289
Change %
Price: $100.00^*
Shares after: 64,289
Date: 27 Nov 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 61,816,346
Exercise price: $0.1040
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Navidea entered into a Loan and Exchange Agreement with the Reporting Person, pursuant to which he surrendered 2,270 shares of Series G Preferred Stock, par value $.001 per share plus accrued and unpaid dividends thereon, and 2,400 shares of Series I Preferred Stock, par value $.001 per share, and other consideration, in exchange for 64,289 shares of Series J Preferred Stock, par value $.001.

Footnote F2

Series J Convertible Preferred Stock, par value $.001 per share, is convertible at any time and has no expiration date.

SEC remarks

Exhibit 24: John K. Scott, Jr. Power of Attorney